These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28253985)

  • 1. Mitochondria-Targeted Molecules as Potential Drugs to Treat Patients With Alzheimer's Disease.
    Reddy AP; Reddy PH
    Prog Mol Biol Transl Sci; 2017; 146():173-201. PubMed ID: 28253985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics.
    Reddy PH; Tripathi R; Troung Q; Tirumala K; Reddy TP; Anekonda V; Shirendeb UP; Calkins MJ; Reddy AP; Mao P; Manczak M
    Biochim Biophys Acta; 2012 May; 1822(5):639-49. PubMed ID: 22037588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
    Reddy PH
    J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. POTENTIAL APPROACHES FOR REDUCING AMYLOID β PRODUCTION.
    Zheng C; Lan Y; Zhang J; Zhang L; Wu J; Guo S
    Acta Pol Pharm; 2016 Jul; 73(4):835-842. PubMed ID: 29648708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecules as therapeutic drugs for Alzheimer's disease.
    Oliver DMA; Reddy PH
    Mol Cell Neurosci; 2019 Apr; 96():47-62. PubMed ID: 30877034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons.
    Reddy PH
    Antioxid Redox Signal; 2007 Oct; 9(10):1647-58. PubMed ID: 17696767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal mitochondria-targeted micelles relieving oxidative stress for delayed progression of Alzheimer's disease.
    Yang P; Sheng D; Guo Q; Wang P; Xu S; Qian K; Li Y; Cheng Y; Wang L; Lu W; Zhang Q
    Biomaterials; 2020 Apr; 238():119844. PubMed ID: 32062148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
    Cai Q; Tammineni P
    J Alzheimers Dis; 2017; 57(4):1087-1103. PubMed ID: 27767992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons.
    Amadoro G; Corsetti V; Florenzano F; Atlante A; Ciotti MT; Mongiardi MP; Bussani R; Nicolin V; Nori SL; Campanella M; Calissano P
    Neurobiol Dis; 2014 Feb; 62():489-507. PubMed ID: 24411077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.
    Verri M; Pastoris O; Dossena M; Aquilani R; Guerriero F; Cuzzoni G; Venturini L; Ricevuti G; Bongiorno AI
    Int J Immunopathol Pharmacol; 2012; 25(2):345-53. PubMed ID: 22697066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative Stress, Mitochondrial Abnormalities and Proteins Deposition: Multitarget Approaches in Alzheimer's Disease.
    Nesi G; Sestito S; Digiacomo M; Rapposelli S
    Curr Top Med Chem; 2017; 17(27):3062-3079. PubMed ID: 28595557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective mitophagy in Alzheimer's disease.
    Pradeepkiran JA; Reddy PH
    Ageing Res Rev; 2020 Dec; 64():101191. PubMed ID: 33022416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial defects: An emerging theranostic avenue towards Alzheimer's associated dysregulations.
    Mani S; Swargiary G; Singh M; Agarwal S; Dey A; Ojha S; Jha NK
    Life Sci; 2021 Nov; 285():119985. PubMed ID: 34592237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease.
    Adiele RC; Adiele CA
    J Alzheimers Dis; 2016 Jul; 53(4):1257-70. PubMed ID: 27392851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics.
    Reddy PH
    J Biomed Biotechnol; 2006; 2006(3):31372. PubMed ID: 17047303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Protective Effect of Icariin on Mitochondrial Transport and Distribution in Primary Hippocampal Neurons from 3× Tg-AD Mice.
    Chen Y; Han S; Huang X; Ni J; He X
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26828481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
    Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
    Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.